Immucor Celebrates 40 Years!
2022 Marks the 40th Anniversary of Immucor's Founding
We are celebrating our employees, our healthcare partners, and the patients we all serve.
Watch this short video from Avi Pelossof, President and CEO
Upcoming Events,
Webinars & Workshops
Upcoming Event
BGS 2026
When
April 23rd 2026
Where
—
Keep Up With Us
News & Blogs
Werfen Introduces NanoTYPE® HLA-11 Plus — First RUO HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the launch of NanoTYPE® HLA-11 Plus, a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes. This new addition to Werfen’s...
News & Blogs
ImmuLINK® Panel ID Algorithm is NOW LAUNCHED!
Are you stressed about inspections, staff adhering to SOPs and maintaining competency with antibody identification...
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary,...
News & Blogs
NEW and Definitely Improved!
You deserve exceptional service/support and our NEW Customer Center is a testament to our commitment...
News & Blogs
Werfen Completes Acquisition of Immucor, Inc.
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November...
